← Back

Example · Veterinary medicine

Sample profile description

“Clinical research on canine and feline osteoarthritis: pain assessment, anti-NGF therapies, rehabilitation. Primary studies and systematic reviews.”

Subject: 3 new papers: Efficacy and safety of relfovetmab administered every three…

Your research digest

Monday 26 October 2026 · 3 new papers

Efficacy and safety of relfovetmab administered every three months for the treatment of pain associated with osteoarthritis in client-owned cats

Becskei C, Cheritel H, Taneja G, et al.

The Veterinary Journal · 2 Oct 2026 · doi:10.1016/j.tvjl.2026.106909

A placebo-controlled field trial in 307 client-owned cats with osteoarthritis tested relfovetmab, an anti-NGF antibody injected every three months. At day 90, 73% of treated cats met the owner-rated success criterion versus 47% on placebo, with benefits from day 3 through nine months. Adverse events were similar between groups apart from more pain on injection.

Why this is for you: Anti-NGF therapy for feline OA pain with a three-monthly dosing schedule.

Relevant · Not relevant

Intra-articular 2.5% polyacrylamide hydrogel provides sustained clinical improvement over 1 year in canine elbow osteoarthritis

Corral JA, Levine D, Barnhard JA, et al.

Journal of the American Veterinary Medical Association · 21 Oct 2026 · doi:10.2460/javma.26.05.0435

Eighteen dogs with CT-confirmed elbow osteoarthritis received an intra-articular polyacrylamide hydrogel injection and were followed for a year. Owner-reported pain, clinician pain scales, range of motion and joint effusion all improved from 3 to 12 months, with only minor, self-limiting side effects. The study was small and had no control group.

Why this is for you: One-year outcomes of an injectable OA treatment, measured with CBPI and Glasgow pain scales.

Relevant · Not relevant

Placebo-controlled randomized clinical study using a collagen hydrolysate-enriched diet in dogs with osteoarthritis

Blees NR, Teunissen M, Smit IH, et al.

The Veterinary Journal · 24 Oct 2026 · doi:10.1016/j.tvjl.2026.106946

In a 12-week double-blind trial, 45 dogs with mild osteoarthritis ate either a collagen hydrolysate-enriched diet or a matched placebo diet. Owner questionnaires and force-plate gait analysis showed no difference between groups; both improved, pointing to a caregiver placebo effect. Nine dogs dropped out, and the sample was small and mixed.

Why this is for you: A negative RCT on a dietary OA intervention, useful when owners ask about supplements.

Relevant · Not relevant